Bank of Montreal’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
CS
Bank of Montreal's XBI Position: Q2 2026 in Review
Bank of Montreal reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.4% in Q2 2026, selling an estimated $6.13M and leaving 789,273 shares worth $125M. The position accounts for 0.04% of the portfolio, ranked #338.
Bank of Montreal first reported a position in XBI in Q2 2014 and has held it in 49 quarters since. 692 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Bank of Montreal held 789,273 shares of State Street SPDR S&P Biotech ETF worth $125M as of Q2 2026.
- Bank of Montreal sold 45,357 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $6.13M.
- State Street SPDR S&P Biotech ETF made up 0.04% of Bank of Montreal's portfolio in Q2 2026, its #338 holding.
- Bank of Montreal first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 49 quarters since.
- 692 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.